StonvexLoading…
StonvexStonvexStonvexCore line items from CPK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $353.10M | $930.00M | $671.10M | $491.50M |
Operating Income | $99.40M | $255.90M | $182.10M | $137.10M |
Net Income | $59.30M | $140.30M | $94.20M | $74.80M |
EPS (Diluted) | $2.47 | $5.97 | $4.03 | $3.22 |
Total Assets | $4.10B | $3.99B | $3.86B | $3.74B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $4.70M | $1.80M | $1.80M | $1.50M |
Free Cash Flow OCF − CapEx | $-23.90M | $-214.90M | $-123.90M | $-74.70M |
Shares Outstanding | 24.05M | 23.49M | 23.36M | 23.22M |